PROSPECTIVE EVALUATION OF MATERNAL SERUM HUMAN CHORIONIC-GONADOTROPIN LEVELS IN 3428 PREGNANCIES

被引:33
作者
BOGART, MH
JONES, OW
FELDER, RA
BEST, RG
BRADLEY, L
BUTTS, W
CRANDALL, B
MACMAHON, W
WIANS, FH
LOEH, PV
机构
[1] UNIV VIRGINIA,CHARLOTTESVILLE,VA 22903
[2] UNIV S CAROLINA,COLUMBIA,SC 29208
[3] ARIZONA INST GENET,CHANDLER,AZ
[4] GRP HLTH COOPERAT,RENTON,WA
[5] UNIV CALIF LOS ANGELES,LOS ANGELES,CA 90024
[6] EMORY UNIV,ATLANTA,GA 30322
[7] USAF,LACKLAND AFB,TX 78236
[8] HYBRITECH INC,LA JOLLA,CA
关键词
HUMAN CHORIONIC GONADOTROPIN; ALPHA-FETOPROTEIN; DOWN SYNDROME; ANEUPLOIDY;
D O I
10.1016/0002-9378(91)90305-B
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
As part of a multicenter prospective study, second-trimester human chorionic gonadotropin and alpha-fetoprotein concentrations were evaluated. Data included maternal age, human chorionic gonadotropin level, alpha-fetoprotein level, weight, race, and pregnancy outcome of 3428 pregnancies at between 15 and 20 weeks' gestation. The results of the study indicate that human chorionic gonadotropin levels decrease as maternal weight increases, that weight-adjusted human chorionic gonadotropin levels for Oriental and black women are higher than for white or Hispanic women, and that twin pregnancies have higher human chorionic gonadotropin levels than singleton pregnancies. Of 255 pregnancies that did not have normal outcomes, 54 (21.2%) had human chorionic gonadotropin levels > 2.0 multiples of the median and 26 (10.2%) had alpha-fetoprotein levels > 2.5 multiples of the median. Of 11 pregnancies with fetal aneuploidy, 6 (54.5%) had human chorionic gonadotropin levels > 2.0 multiples of the median. It is concluded that in human chorionic gonadotropin screening programs for fetal Down syndrome, weight and race adjustments are necessary for accurate risk assessment.
引用
收藏
页码:663 / 667
页数:5
相关论文
共 22 条
[1]   MATERNAL LEVELS OF PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN (SP-1) ARE ELEVATED IN PREGNANCIES AFFECTED BY DOWNS-SYNDROME [J].
BARTELS, I ;
LINDEMANN, A .
HUMAN GENETICS, 1988, 80 (01) :46-48
[2]   MATERNAL SERUM HCG AND SP1 IN PREGNANCIES WITH FETAL ANEUPLOIDY [J].
BARTELS, I ;
THIELE, M ;
BOGART, MH .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1990, 37 (02) :261-264
[3]   CIGARETTE-SMOKING IN PREGNANCY RESULTS IN MARKED DECREASE IN MATERNAL HCG AND ESTRADIOL LEVELS [J].
BERNSTEIN, L ;
PIKE, MC ;
LOBO, RA ;
DEPUE, RH ;
ROSS, RK ;
HENDERSON, BE .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1989, 96 (01) :92-96
[4]   HUMAN CHORIONIC-GONADOTROPIN LEVELS IN PREGNANCIES WITH ANEUPLOID FETUSES [J].
BOGART, MH ;
GOLBUS, MS ;
SORG, ND ;
JONES, OW .
PRENATAL DIAGNOSIS, 1989, 9 (06) :379-384
[5]   ABNORMAL MATERNAL SERUM CHORIONIC-GONADOTROPIN LEVELS IN PREGNANCIES WITH FETAL CHROMOSOME-ABNORMALITIES [J].
BOGART, MH ;
PANDIAN, MR ;
JONES, OW .
PRENATAL DIAGNOSIS, 1987, 7 (09) :623-630
[6]  
CANICK JA, 1988, BRIT J OBSTET GYNAEC, V95, P334
[7]  
CUCKLE HS, 1984, LANCET, V1, P926
[8]   THE EFFECT OF SMOKING IN PREGNANCY ON MATERNAL SERUM ALPHA-FETOPROTEIN, UNCONJUGATED ESTRIOL, HUMAN CHORIONIC-GONADOTROPIN, PROGESTERONE AND DEHYDROEPIANDROSTERONE SULFATE LEVELS [J].
CUCKLE, HS ;
WALD, NJ ;
DENSEM, JW ;
ROYSTON, P ;
KNIGHT, GJ ;
HADDOW, JE ;
PALOMAKI, GE ;
CANICK, JA .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1990, 97 (03) :272-274
[9]   EPIDEMIOLOGY OF GESTATIONAL TROPHOBLASTIC DISEASE [J].
GRIMES, DA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1984, 150 (03) :309-318
[10]   USE OF MATERNAL SERUM ALPHA-FETOPROTEIN MEASUREMENTS TO SCREEN FOR DOWNS-SYNDROME [J].
KNIGHT, GJ ;
PALOMAKI, GE ;
HADDOW, JE .
CLINICAL OBSTETRICS AND GYNECOLOGY, 1988, 31 (02) :306-327